# Doctor Anywhere Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/doctor-anywhere-pte

- Industry: Healthcare IT
- Headquarters: Singapore, Singapore
- Website: www.doctoranywhere.com
- Total disclosed funding: $174M
- Latest round: Series C (Dec 7, 2023)
- Investors on record: 11

## About

Based in Singapore, Doctor Anywhere Pte. Ltd. is a healthcare technology company that provides comprehensive telehealth services and medical solutions, enhancing access to healthcare for individuals and families across Southeast Asia.Doctor Anywhere Pte. Ltd. was founded in 2017 in Singapore and operates as a healthcare platform specializing in telehealth services. The company has successfully completed a total of 7 funding deals, with its most recent being a Series C round on December 7, 2023, raising USD 40.8 mn from Novo Holdings and Square Peg. Wai Lim serves as the CEO and founder of the company.Doctor Anywhere offers a wide range of healthcare solutions including a telehealth app, physical clinics, health screening centers, and mobile medical teams. The platform allows users to book appointments with healthcare professionals and access various services such as mental wellness support, preventive health screenings, and vaccinations, catering to over 2.8 million users across Singapore, Thailand, Malaysia, the Philippines, and Indonesia.In the most recent fiscal year of 2023, Doctor Anywhere generated revenue amounting to USD 81.71 mn, with an EBITDA of USD -22.83 mn, reflecting the company's operational performance during that period.Following the completion of its Series C funding round on December 7, 2023, in which Doctor Anywhere raised USD 40.8 mn, the company plans to enhance its healthcare offerings. The funding will support the development of solutions such as predictive healthcare needs assessments and improved appointment scheduling systems. Additionally, Doctor Anywhere aims to expand its presence into new markets, although specific regions and timelines for this expansion have not been disclosed.

## Funding rounds

- Series C, Dec 7, 2023, $41M — Novo Holdings, Square Peg
- Series C, Jan 12, 2023, $39M — SG Growth Capital, IHH Healthcare Berhad, Novo Holdings, Square Peg, OSK Ventures International Berhad, Asia Partners, Kamet Capital Partners, MVM1 Limited
- Series C, Aug 31, 2021, $66M — SG Growth Capital, Koninklijke Philips N.V., Parkway Holdings, Pavilion Capital, Novo Holdings, Square Peg, OSK Ventures International Berhad, Asia Partners, MVM1 Limited
- Series B, Mar 26, 2020, $26M — SG Growth Capital, Parkway Holdings, Pavilion Capital, Square Peg, Kamet Capital Partners, MVM1 Limited
- Series A, Jun 26, 2018, $2.6M — Kamet Capital Partners, MVM1 Limited

## Investors

- Kamet Capital Partners (https://capitalatlas.ai/funds/kamet-capital-partners) — Series A, Series B, Series C
- MVM1 Limited — Series A, Series B, Series C
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series B, Series C
- Parkway Holdings — Series B, Series C
- Pavilion Capital — Series B, Series C
- Square Peg (https://capitalatlas.ai/funds/square-peg) — Series B, Series C
- Koninklijke Philips N.V. — Series C
- Novo Holdings — Series C
- OSK Ventures International Berhad (https://capitalatlas.ai/funds/osk-ventures-international-berhad) — Series C
- Asia Partners (https://capitalatlas.ai/funds/asia-partners) — Series C
- IHH Healthcare Berhad — Series C